Wessex Medical Financial Services Limited 12579084 false 2023-05-01 2024-04-30 2024-04-30 The principal activity of the company is the provision of financial management services. Digita Accounts Production Advanced 6.30.9574.0 true true 12579084 2023-05-01 2024-04-30 12579084 2024-04-30 12579084 bus:Director1 1 2024-04-30 12579084 bus:OrdinaryShareClass1 2024-04-30 12579084 bus:OrdinaryShareClass2 2024-04-30 12579084 bus:OrdinaryShareClass3 2024-04-30 12579084 bus:OrdinaryShareClass4 2024-04-30 12579084 bus:OrdinaryShareClass5 2024-04-30 12579084 core:RetainedEarningsAccumulatedLosses 2024-04-30 12579084 core:ShareCapital 2024-04-30 12579084 core:CurrentFinancialInstruments 2024-04-30 12579084 core:CurrentFinancialInstruments core:WithinOneYear 2024-04-30 12579084 core:Non-currentFinancialInstruments core:AfterOneYear 2024-04-30 12579084 core:FurnitureFittingsToolsEquipment 2024-04-30 12579084 core:MotorVehicles 2024-04-30 12579084 bus:SmallEntities 2023-05-01 2024-04-30 12579084 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 12579084 bus:FilletedAccounts 2023-05-01 2024-04-30 12579084 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 12579084 bus:RegisteredOffice 2023-05-01 2024-04-30 12579084 bus:Director1 2023-05-01 2024-04-30 12579084 bus:Director1 1 2023-05-01 2024-04-30 12579084 bus:Director2 2023-05-01 2024-04-30 12579084 bus:OrdinaryShareClass1 2023-05-01 2024-04-30 12579084 bus:OrdinaryShareClass2 2023-05-01 2024-04-30 12579084 bus:OrdinaryShareClass3 2023-05-01 2024-04-30 12579084 bus:OrdinaryShareClass4 2023-05-01 2024-04-30 12579084 bus:OrdinaryShareClass5 2023-05-01 2024-04-30 12579084 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 12579084 bus:Agent1 2023-05-01 2024-04-30 12579084 core:FurnitureFittingsToolsEquipment 2023-05-01 2024-04-30 12579084 core:MotorVehicles 2023-05-01 2024-04-30 12579084 core:OfficeEquipment 2023-05-01 2024-04-30 12579084 countries:EnglandWales 2023-05-01 2024-04-30 12579084 2023-04-30 12579084 bus:Director1 1 2023-04-30 12579084 core:FurnitureFittingsToolsEquipment 2023-04-30 12579084 core:MotorVehicles 2023-04-30 12579084 2022-05-01 2023-04-30 12579084 2023-04-30 12579084 bus:Director1 1 2023-04-30 12579084 bus:OrdinaryShareClass1 2023-04-30 12579084 bus:OrdinaryShareClass2 2023-04-30 12579084 bus:OrdinaryShareClass3 2023-04-30 12579084 bus:OrdinaryShareClass4 2023-04-30 12579084 bus:OrdinaryShareClass5 2023-04-30 12579084 core:RetainedEarningsAccumulatedLosses 2023-04-30 12579084 core:ShareCapital 2023-04-30 12579084 core:CurrentFinancialInstruments 2023-04-30 12579084 core:CurrentFinancialInstruments core:WithinOneYear 2023-04-30 12579084 core:Non-currentFinancialInstruments core:AfterOneYear 2023-04-30 12579084 core:FurnitureFittingsToolsEquipment 2023-04-30 12579084 core:MotorVehicles 2023-04-30 12579084 bus:Director1 1 2022-05-01 2023-04-30 12579084 bus:OrdinaryShareClass5 2022-05-01 2023-04-30 12579084 bus:Director1 1 2022-04-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12579084

Wessex Medical Financial Services Limited

Unaudited Filleted Financial Statements

for the Year Ended 30 April 2024

 

Wessex Medical Financial Services Limited

Contents

Company Information

1

Accountants' Report

2

Statement of Income and Retained Earnings

3

Balance Sheet

4 to 5

Notes to the Unaudited Financial Statements

6 to 11

 

Wessex Medical Financial Services Limited

Company Information

Directors

Mr Owen Beswick

Elizabeth Ann Beswick

Registered office

Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

Accountants

MMO Limited
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

 

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Wessex Medical Financial Services Limited
for the Year Ended 30 April 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Wessex Medical Financial Services Limited for the year ended 30 April 2024 as set out on pages 3 to 11 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Wessex Medical Financial Services Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Wessex Medical Financial Services Limited and state those matters that we have agreed to state to the Board of Directors of Wessex Medical Financial Services Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Wessex Medical Financial Services Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Wessex Medical Financial Services Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Wessex Medical Financial Services Limited. You consider that Wessex Medical Financial Services Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Wessex Medical Financial Services Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

MMO Limited
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

9 January 2025

 

Wessex Medical Financial Services Limited

Profit and Loss Account and Statement of Retained Earnings for the Year Ended 30 April 2024

Note

2024
£

2023
£

Turnover

 

198,842

159,171

Administrative expenses

 

(71,479)

(31,328)

Operating profit

 

127,363

127,843

Other interest receivable and similar income

 

81

-

Interest payable and similar charges

 

(5,342)

(5,112)

 

(5,261)

(5,112)

Profit before tax

122,102

122,731

Taxation

 

(29,286)

(28,506)

Profit for the financial year

 

92,816

94,225

Retained earnings brought forward

 

1,048

26,823

Dividends paid

 

(93,500)

(120,000)

Retained earnings carried forward

 

364

1,048

 

Wessex Medical Financial Services Limited

(Registration number: 12579084)
Balance Sheet as at 30 April 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

66,418

88,427

Current assets

 

Debtors

5

53,704

20,458

Cash at bank and in hand

 

7,330

6,592

 

61,034

27,050

Creditors: Amounts falling due within one year

6

(47,004)

(18,070)

Net current assets

 

14,030

8,980

Total assets less current liabilities

 

80,448

97,407

Creditors: Amounts falling due after more than one year

6

(63,339)

(74,122)

Provisions for liabilities

(16,605)

(22,107)

Net assets

 

504

1,178

Capital and reserves

 

Called up share capital

7

140

130

Retained earnings

364

1,048

Shareholders' funds

 

504

1,178

For the financial year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 9 January 2025 and signed on its behalf by:
 

 

Wessex Medical Financial Services Limited

(Registration number: 12579084)
Balance Sheet as at 30 April 2024

.........................................
Mr Owen Beswick
Director

 

Wessex Medical Financial Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

All figures are presented in British Sterling, which is the functional currency of the company, and are rounded to the nearest £1.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

 

Wessex Medical Financial Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office Equipment

25% - Straight line

Motor Vehicles

25% - Reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

Wessex Medical Financial Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

 

Wessex Medical Financial Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost or valuation

At 1 May 2023

3,634

89,600

93,234

Additions

489

-

489

At 30 April 2024

4,123

89,600

93,723

Depreciation

At 1 May 2023

1,074

3,733

4,807

Charge for the year

1,031

21,467

22,498

At 30 April 2024

2,105

25,200

27,305

Carrying amount

At 30 April 2024

2,018

64,400

66,418

At 30 April 2023

2,560

85,867

88,427

5

Debtors

Current

2024
£

2023
£

Trade debtors

23,699

16,510

Prepayments

1,790

1,025

Other debtors

28,215

2,923

 

53,704

20,458

 

Wessex Medical Financial Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

6

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

10,783

10,140

Taxation and social security

 

34,721

6,430

Accruals and deferred income

 

1,500

1,500

 

47,004

18,070

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

63,339

74,122

7

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

Ordinary A shares of £1 each

10

10

10

10

Ordinary B shares of £1 each

10

10

10

10

Ordinary C shares of £1 each

10

10

10

10

Ordinary D shares of £1 (2023 - £0) each

10

10

-

-

140

140

130

130

 

Wessex Medical Financial Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

8

Related party transactions

Transactions with directors

2024

At 1 May 2023
£

Other payments made to company by director
£

At 30 April 2024
£

Mr Owen Beswick

The directors loan account balance is undated, unsecured, interest free and repayable on demand.

2,923

25,293

28,215

2023

At 1 May 2022
£

Other payments made to company by director
£

At 30 April 2023
£

Mr Owen Beswick

The directors loan account balance is undated, unsecured, interest free and repayable on demand.

(7)

2,929

2,923